[go: up one dir, main page]

AU2001255730A1 - Methods and compositions for the treatment of cardiac indications - Google Patents

Methods and compositions for the treatment of cardiac indications

Info

Publication number
AU2001255730A1
AU2001255730A1 AU2001255730A AU5573001A AU2001255730A1 AU 2001255730 A1 AU2001255730 A1 AU 2001255730A1 AU 2001255730 A AU2001255730 A AU 2001255730A AU 5573001 A AU5573001 A AU 5573001A AU 2001255730 A1 AU2001255730 A1 AU 2001255730A1
Authority
AU
Australia
Prior art keywords
compositions
treatment
methods
cardiac indications
cardiac
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001255730A
Inventor
Balaji Venkataraman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi Pharma Inc
Original Assignee
First Horizon Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by First Horizon Pharmaceutical Corp filed Critical First Horizon Pharmaceutical Corp
Publication of AU2001255730A1 publication Critical patent/AU2001255730A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2001255730A 2000-04-26 2001-04-26 Methods and compositions for the treatment of cardiac indications Abandoned AU2001255730A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20015700P 2000-04-26 2000-04-26
US60/200,157 2000-04-26
PCT/US2001/013579 WO2001080895A2 (en) 2000-04-26 2001-04-26 Methods and compositions for the treatment of cardiac indications

Publications (1)

Publication Number Publication Date
AU2001255730A1 true AU2001255730A1 (en) 2001-11-07

Family

ID=22740566

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001255730A Abandoned AU2001255730A1 (en) 2000-04-26 2001-04-26 Methods and compositions for the treatment of cardiac indications

Country Status (3)

Country Link
US (1) US20010039262A1 (en)
AU (1) AU2001255730A1 (en)
WO (1) WO2001080895A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7550133B2 (en) 2002-11-26 2009-06-23 Alexza Pharmaceuticals, Inc. Respiratory drug condensation aerosols and methods of making and using them
WO2004104490A1 (en) 2003-05-21 2004-12-02 Alexza Pharmaceuticals, Inc. Self-contained heating unit and drug-supply unit employing same
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
AU2004322756B2 (en) 2004-08-12 2011-04-14 Alexza Pharmaceuticals, Inc. Aerosol drug delivery device incorporating percussively activated heat packages
US20080216828A1 (en) 2007-03-09 2008-09-11 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
WO2013115476A1 (en) * 2012-01-31 2013-08-08 국립암센터 Composition for aggregating biological sample, method for preparing paraffin block using same, and method for preparing specimen of cell block using the paraffin block for cell microarray
US12214118B2 (en) 2018-02-02 2025-02-04 Alexza Pharmaceuticals, Inc. Electrical condensation aerosol device

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3532036A1 (en) * 1985-09-09 1987-03-26 Hoechst Ag PHARMACEUTICAL PREPARATION FOR TREATING HIGH PRESSURE
ATE122228T1 (en) * 1991-07-01 1995-05-15 Gergely Gerhard METHOD FOR PRODUCING A PHARMACEUTICAL PREPARATION WITH AT LEAST TWO DIFFERENT ACTIVE INGREDIENTS AND USE OF SUCH A PREPARATION.
DK9200258U4 (en) * 1992-03-11 1993-07-23 Merck & Co Inc Pharmaceutical preparation containing enalapril for use in hypertension
AU4866196A (en) * 1995-02-10 1996-08-27 G.D. Searle & Co. Combination of angiotensin converting enzyme inhibitor, side-effect-reduced amount of aldosterone antagonist and diuretic
DE69628821T2 (en) * 1995-02-10 2004-05-06 G.D. Searle & Co., Skokie COMBINATION OF ACE INHIBITORS WITH ALDOSTERONANTAGONISTS FOR THE TREATMENT OF VENTRICULAR HYPERTROPHY
EP1126880A2 (en) * 1998-11-06 2001-08-29 G.D. SEARLE & CO. Combination therapy of angiotensin converting enzyme inhibitor and aldosterone antagonist for reducing morbidity and mortality from cardiovascular disease
EP1165136B1 (en) * 1999-03-05 2003-09-10 G.D. Searle LLC Combination therapy of angiotensin converting enzyme inhibitor and epoxy-steroidal aldosterone antagonist for treatment of cardiovascular disease

Also Published As

Publication number Publication date
US20010039262A1 (en) 2001-11-08
WO2001080895A2 (en) 2001-11-01
WO2001080895A3 (en) 2002-08-08

Similar Documents

Publication Publication Date Title
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
AU2495200A (en) Compositions and methods for the treatment of tumor
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2001249881A1 (en) Method of treating the heart
AU2212299A (en) Compositions and methods for the treatment of tumor
AU2001233081A1 (en) Composition for treatment of stress
AU3632600A (en) Compositions and methods for the treatment of immune related diseases
AU2001255730A1 (en) Methods and compositions for the treatment of cardiac indications
AU4511201A (en) Compositions and methods for the induction and treatment of retinal detachments
AU2001264522A1 (en) Methods and compositions for the prevention of myopia
AU1878201A (en) Composition for the treatment of damaged tissue
AU4228000A (en) Methods and compositions for the treatment and prevention of lung disease
AU3434601A (en) Compositions and methods for the treatment of immune related diseases
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
AU2001271284A1 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
AU2420101A (en) Method and composition for the treatment of pain
AU4839100A (en) Methods of using and compositions comprising n-desmethylzolpidem
AU2001296224A1 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
AU4225500A (en) Methods and compositions for the treatment and prevention of lung disease
AU2001255168A1 (en) Compositions and methods for the treatment of immune related diseases
AU2683500A (en) Compositions for the treatment of pain
AU2001253469A1 (en) Compositions and methods for stabilizing modified tissue
AU2001253560A1 (en) Methods of treatment